IDiyas

For the Inventor, By the Inventor

Bend, OR, United States of America

Scott Bone

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 152(Granted Patents)


Company Filing History:

goldMedal20 out of 84 
 
Deciphera Pharmaceuticals, LLC
 patents
silverMedal4 out of 549 
 
Celgene Corporation
 patents

Years Active: 2020-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 12318374 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-06-03),
2. 12226406 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-18),
3. 12213968 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
4. 12213967 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
5. 12064422 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-08-20),
6. 12023328 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-07-02),
7. 11969415 - (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-04-30),
8. 11918564 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-03-05),
9. 11911370 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-27),
10. 11903933 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2024-02-20),
11. 11896585 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea (2024-02-13),
12. 11850241 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),
13. 11850240 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-26),
14. 11844788 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2023-12-19),
15. 11801237 - Amorphous kinase inhibitor formulations and methods of use thereof (2023-10-31),

Title: Innovations by Scott Bone: A Closer Look at His Contributions

Introduction

Scott Bone is a notable inventor based in Bend, OR, with an impressive portfolio of 23 patents. His work primarily revolves around innovative compositions that address significant medical conditions by targeting specific kinases. This article delves into his latest patents, career highlights, and collaborations, showcasing the impact of his contributions in the field of pharmaceuticals.

Latest Patents

Among Scott Bone's latest patents are compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea. These low impurity compositions are crucial in the treatment of disorders related to the activity of c-KIT and PDGFRα kinases, as well as their oncogenic forms. The specificity and efficacy of these compositions highlight the innovative nature of Bone's inventions.

Career Highlights

Scott Bone has made significant contributions to the pharmaceutical industry through his work at renowned companies such as Deciphera Pharmaceuticals, LLC and Celgene Corporation. His expertise in developing novel therapeutic compositions has set him apart as an inventor committed to advancing healthcare solutions.

Collaborations

Throughout his career, Scott has collaborated with respected professionals, including Corey Bloom and Fred Jordan. These collaborations reflect his ability to work within teams to drive innovation and achieve groundbreaking results in the development of new pharmaceutical products.

Conclusion

Scott Bone's extensive patent portfolio and his dedication to innovation significantly contribute to advancements in medical treatments. His work demonstrates the vital role inventors play in addressing health challenges, and his continued efforts promise to further impact the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…